![]() |
Hey, all — this could be the real deal. Reuters is reporting that tests on the drug, tasimelteon — also known as VEC-162 — show it has the potential to work for people with “transient insomnia”. Meaning people who work the late-shift, as well as people who suffer from jet-lag. Testing is being carried out at Boston’s Brigham and Women’s Hospital and Harvard Medical School, in conjunction with the drug’s developer, Maryland-based Vanda Pharmaceuticals. Here’s some of the initial findings: people using tasimelteon “fell asleep faster, had better sleep and woke up faster”. |



No Comments »
No comments yet.
RSS feed for comments on this post. | TrackBack URI
Leave a comment